Please use this identifier to cite or link to this item: http://hdl.handle.net/10739/3175
Title: Denouncing trade agreements validating pharmaceutical developers’ term extensions
Authors: Tripathy, Sunita
Keywords: CPTPP
Free trade agreements
Patent linkage
Pharmaceutical companies
Medicinal compounds
TRIPS plus norms
Term extensions
Issue Date: 30-Oct-2018
Publisher: Springer, Singapore
Citation: Tripathy, S. (2018). Denouncing trade agreements validating pharmaceutical developers’ term extensions. In L. Corbin & M. Perry (Eds.), Free trade agreements: Hegemony or harmony (pp. 139–161). Springer Singapore.
Abstract: Free Trade agreements have had extraordinary effects on the production and use of pharmaceuticals in India. Following the Word Trade Organisation’s Agreement on Trade Related Aspects of Intellectual Property, there has been a plethora of attempts at the level of international trade negotiations to extend the rights of pharmaceutical companies over medicinal compounds. This chapter explores this area’s developments showing how it has been a detrimental development for countries such as India.
URI: http://hdl.handle.net/10739/3175
ISBN: 9789811330384
Appears in Collections:JGU Research Publications

Files in This Item:
File Description SizeFormat 
Denouncing Trade Agreements.pdfDenouncing Trade Agreements Validating Pharmaceutical Developers’ Term Extensions268.7 kBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.